Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity

Author： Amstutz Ursula Froehlich Tanja K Largiadèr Carlo R

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.12, Iss.9, 2011-09, pp. : 1321-1336

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Dihydropyrimidine dehydrogenase gene variation and severe 5-fluorouracil toxicity: a haplotype assessment

By Amstutz Ursula Farese Simone Aebi Stefan Largiadèèr Carlo R

Pharmacogenomics, Vol. 10, Iss. 6, 2009-06 ,pp. : 931-944

Future Medicine

Access to resources Recommend Favorite

Implications of dihydropyrimidine dehydrogenase on 5-fluorouracil pharmacogenetics and pharmacogenomics

By Mattison Lori K Soong Richie Diasio Robert B

Pharmacogenomics, Vol. 3, Iss. 4, 2002-07 ,pp. : 485-492

Future Medicine

Access to resources Recommend Favorite

Capecitabine: Severe toxicity and death in a patient with dihydropyrimidine dehydrogenase deficiency: case report

Reactions Weekly, Vol. 1, Iss. 1174, 2007-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Variants in the Dihydropyrimidine Dehydrogenase, Methylenetetrahydrofolate Reductase and Thymidylate Synthase Genes Predict Early Toxicity of 5-Fluorouracil in Colorectal Cancer Patients

By Kristensen MH Pedersen PL Melsen GV Ellehauge J Mejer J

The Journal of International Medical Research, Vol. 38, Iss. 3, 2010-06 ,pp. : 870-883

Field House Publishing

Access to resources Recommend Favorite

The Effect of Dihydropyrimidine Dehydrogenase Deficiency on Outcomes with Fluorouracil

By Gardiner S.J.

Adverse Drug Reactions & Toxicological Reviews (now known as Toxicological Reviews), Vol. 21, Iss. 1-2, 2002-01 ,pp. : 1-16

Adis International

Access to resources Recommend Favorite